Worldwide Prevention, Shared Protection
Why STI Funding Matters
This Issue Brief describes the impacts of the elimination and reduction of funding that supports sexually transmitted infection (STI) research, testing, and prevention programming. This funding is critically important as STI rates continue to increase globally with more than 1 million curable STIs, including chlamydia, gonorrhea, syphilis, and trichomoniasis, acquired every day. Without appropriate testing, treatment, and prevention programs, there is a risk that STI rates will continue to increase leading to more cases of infertility, pelvic inflammatory disease, and cancers. Further, there is the risk that we will lose the ability to monitor, react to, and prevent the rise of antimicrobial resistant gonorrhea, which has become an issue for the majority of treatment options currently available.
- Topics:
- Advocating for Health Equity
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!